Literature DB >> 20159612

Modeling antibody-enhanced dengue virus infection and disease in mice: protection or pathogenesis?

Theodore C Pierson1.   

Abstract

While antibodies play an important protective role during dengue virus infection, they have also been linked to more severe clinical outcomes. In this issue of Cell Host & Microbe, Zellweger and colleagues (Zellweger et al., 2010) describe the development of a murine model of antibody-enhanced dengue virus infection that provides a formal link between immune enhancement and severe disease. 2010 Elsevier Inc. All rights reserved.

Entities:  

Year:  2010        PMID: 20159612     DOI: 10.1016/j.chom.2010.02.004

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN: 1931-3128            Impact factor:   21.023


  11 in total

1.  Dengue Virus Infection with Highly Neutralizing Levels of Cross-Reactive Antibodies Causes Acute Lethal Small Intestinal Pathology without a High Level of Viremia in Mice.

Authors:  Satoru Watanabe; Kitti Wing Ki Chan; Jiaqi Wang; Laura Rivino; Shee-Mei Lok; Subhash G Vasudevan
Journal:  J Virol       Date:  2015-03-18       Impact factor: 5.103

2.  Persistence of circulating memory B cell clones with potential for dengue virus disease enhancement for decades following infection.

Authors:  Scott A Smith; Yang Zhou; Nicholas P Olivarez; Anne H Broadwater; Aravinda M de Silva; James E Crowe
Journal:  J Virol       Date:  2011-12-14       Impact factor: 5.103

Review 3.  Innate Immune Response to Dengue Virus: Toll-like Receptors and Antiviral Response.

Authors:  Caroline Fernandes-Santos; Elzinandes Leal de Azeredo
Journal:  Viruses       Date:  2022-05-07       Impact factor: 5.818

4.  Subneutralizing antibodies to enterovirus 71 induce antibody-dependent enhancement of infection in newborn mice.

Authors:  I-Chun Chen; Shih-Min Wang; Chun-Keung Yu; Ching-Chuan Liu
Journal:  Med Microbiol Immunol       Date:  2013-02-14       Impact factor: 3.402

5.  The complexity of antibody-dependent enhancement of dengue virus infection.

Authors:  Maria G Guzman; Susana Vazquez
Journal:  Viruses       Date:  2010-12-08       Impact factor: 5.048

6.  Subversion of innate defenses by the interplay between DENV and pre-existing enhancing antibodies: TLRs signaling collapse.

Authors:  Naphak Modhiran; Siripen Kalayanarooj; Sukathida Ubol
Journal:  PLoS Negl Trop Dis       Date:  2010-12-21

7.  An Epitope-Substituted DNA Vaccine Improves Safety and Immunogenicity against Dengue Virus Type 2.

Authors:  Chung-Tao Tang; Pi-Chun Li; I-Ju Liu; Mei-Ying Liao; Chiung-Yi Chiu; Day-Yu Chao; Han-Chung Wu
Journal:  PLoS Negl Trop Dis       Date:  2015-07-02

Review 8.  The role of viral persistence in flavivirus biology.

Authors:  Luwanika Mlera; Wessam Melik; Marshall E Bloom
Journal:  Pathog Dis       Date:  2014-05-12       Impact factor: 3.166

9.  Antibody-mediated enhancement aggravates chikungunya virus infection and disease severity.

Authors:  Fok-Moon Lum; Thérèse Couderc; Bing-Shao Chia; Ruo-Yan Ong; Zhisheng Her; Angela Chow; Yee-Sin Leo; Yiu-Wing Kam; Laurent Rénia; Marc Lecuit; Lisa F P Ng
Journal:  Sci Rep       Date:  2018-01-30       Impact factor: 4.379

Review 10.  New insights into the immunopathology and control of dengue virus infection.

Authors:  Gavin Screaton; Juthathip Mongkolsapaya; Sophie Yacoub; Catherine Roberts
Journal:  Nat Rev Immunol       Date:  2015-12       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.